留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

家族性地中海热的神经系统临床表现

董耀华 宋红梅

董耀华, 宋红梅. 家族性地中海热的神经系统临床表现[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2022-0093
引用本文: 董耀华, 宋红梅. 家族性地中海热的神经系统临床表现[J]. 协和医学杂志. doi: 10.12290/xhyxzz.2022-0093
DONG Yaohua, SONG Hongmei. Neurological Manifestations in Familial Mediterranean Fever[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2022-0093
Citation: DONG Yaohua, SONG Hongmei. Neurological Manifestations in Familial Mediterranean Fever[J]. Medical Journal of Peking Union Medical College Hospital. doi: 10.12290/xhyxzz.2022-0093

家族性地中海热的神经系统临床表现

doi: 10.12290/xhyxzz.2022-0093
基金项目: 

国家重点研发计划(2021YFC2702001)

北京市自然科学基金-海淀原始创新联合基金资助(L202050)

详细信息
    通讯作者:

    宋红梅,E-mail:songhm1021@126.com

  • 中图分类号: R593;R596;R741

Neurological Manifestations in Familial Mediterranean Fever

Funds: 

National Key Research and Development Program of China (2021YFC2702001)

Beijing Natural Science Foundation (L202050)

  • 摘要: 家族性地中海热(familial Mediterranean fever,FMF)是一种由 MEFV基因突变导致的自身炎症性疾病,主要临床表现为反复发作的发热和全身多处浆膜炎症,部分 FMF患者还可出现神经系统临床表现,如癫痫、脱髓鞘疾病、无菌性脑膜炎等。由于 FMF患者的神经系统临床表现较为罕见,临床中易忽视二者间的联系。本文针对 FMF的重要神经系统临床表现及其与基因型的关系进行阐述,以加深对 FMF的认识,为临床诊疗提供借鉴和参考。
  • [1] Ozen S. Update in familial Mediterranean fever[J]. Curr Opin Rheumatol, 2021, 33:398-402.
    [2] Bhatt H, Cascella M. Familial Mediterranean Fever[M]. In StatPearls, StatPearls Publishing, 2022.
    [3] Shinar Y, Ceccherini I, Rowczenio D, et al. ISSAID/EMQN Best practice guidelines for the genetic diagnosis of Monognenic AIDs in the next generaion sequencing era[J]. Clin Chem, 2020, 66:525-536.
    [4] Gedalia A, Zamir S. Neurologic manifestations in familial Mediterranean fever[J]. Pediatr Neurol, 1993, 9:301-302.
    [5] Ertekin V, Selimoglu MA, Pirim I. Familial Mediterranean fever in a childhood population in eastern Turkey[J]. Pediatr Int, 2005, 47:640-644.
    [6] Canpolat M, Gumus H, Gunduz Z, et al. Neurological Manifestations in Familial Mediterranean Fever:Results of 22 Children from a Reference Center in Kayseri, an Urban Area in Central Anatolia, Turkey[J]. Neuropediatrics, 2017, 48:79-85.
    [7] Canpolat M, Kumandas S, Poyrazoglu HG, et al. Prevalence and risk factors of epilepsy among school children in Kayseri City Center, an urban area in Central Anatolia, Turkey[J]. Seizure, 2014, 23:708-716.
    [8] Salehzadeh F, Azami A, Motezarre M, et al. Neurological Manifestations in Familial Mediterranean Fever:a Genotype-Phenotype Correlation Study[J]. Open Access Rheumatol, 2020, 12:15-19.
    [9] World Health Organization. Epilepsy in the WHO Eastern Mediterranean region:bridging the gap[EB/M].[2022-03-01].https://apps.who.int/iris/handle/10665/119905.
    [10] Çomak E, Tüfekçi Ö, Kılıçbay F, et al. Febrile seizures in children with familial Mediterranean fever:Coincidence or association?[J]. Eur J Paediatr Neurol, 2015, 19:572-576.
    [11] Carman KB, Ekici A, Yimenicioglu S, et al. The prevalence of febrile seizure and associated factors among Turkish children[J]. Int J Clin Pediatr, 2014, 3:1-4.
    [12] Okan N, Okan M, Eralp O, et al. The prevalence of neurological disorders among children in Gemlik (Turkey)[J]. Dev Med Child Neurol, 1995, 37:597-603.
    [13] Yakinci C, Kutlu NO, Durmaz Y, et al. Prevalence of febrile convulsion in 3637 children of primary school age in the province of Malatya[J]. Turk J Trop Pediatr, 2000, 46:249-250.
    [14] Özen F, Kocak N, Kelekci S, et al. The prevalence of Familial Mediterranean Fever common gene mutations in patients with simple febrile seizures[J]. Eur Rev Med Pharmacol Sci, 2014, 18:657-660.
    [15] Biro O, Gileles-Hillel A, Dor-Wollman T, et al. Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings[J].Eur J Pediatr, 2022, 181:973-978.
    [16] Akman-Demir G, Gul A, Gurol E, et al. Inflammatory/demyelinating central nervous system involvement in familial Mediterranean fever (FMF):coincidence or association?[J] J Neurol, 2006, 253:928-934.
    [17] Unal A, Dursun A, Emre U, et al. Evaluation of common mutations in the Mediterranean fever gene in Multiple Sclerosis patients:is it a susceptibility gene?[J]. J Neurol Sci, 2010, 294:38-42.
    [18] Shinar Y, Livneh A, Villa Y, et al. Common mutations in the familial Mediterranean fever gene associate with rapid progression to disability in non-Ashkenazi Jewish multiple sclerosis patients[J].Genes Immun, 2003, 4:197-203.
    [19] Kalyoncu U, Eker A, Oguz KK, et al. Familial Mediterranean fever and central nervous system involvement:a case series[J]. Medicine, 2010, 89:75-84.
    [20] Yahalom G, Kivity S, Lidar M, et al. Familial Mediterranean fever (FMF) and multiple sclerosis:an association study in one of the world's largest FMF cohorts[J]. Eur J Neurol, 2011, 18:1146-1150.
    [21] Furlan R, Filippi M, Bergami A, et al. Peripheral levels of caspase-1 mRNA correlate with disease activity in patients with multiple sclerosis; a preliminary study[J]. J Neurol Neurosurg Psychiatry, 1999, 67:785-788.
    [22] Elhani I, Dumont A, Vergneault H, et al. Association between familial Mediterranean fever and multiple sclerosis:A case series from the JIR cohort and systematic literature review[J].Mult Scler Relat Disord, 2021, 50:102834.
    [23] Gedalia A, Zamir S. Neurologic manifestations in familial Mediterranean fever[J]. Pediatr Neurol, 1993, 9:301-302.
    [24] Karachaliou I, Karachalios G, Charalabopoulos A, et al. Meningitis associated with familial Mediterranean fever[J]. Int J Clin Pract Suppl, 2005, 147:60-61.
    [25] Schwabe AD, Monroe JB. Meningitis in familial Mediterranean fever[J]. Am J Med, 1988, 85:715-717.
    [26] Barakat MH, Mustafa HT, Shakir RA. Mollaret's meningitis. A variant of recurrent hereditary polyserositis, both provoked by metaraminol[J]. Arch Neurol, 1988, 45:926-927.
    [27] Feld O, Yahalom G, Livneh A. Neurologic and other systemic manifestations in FMF:published and own experience[J]. Best Pract Res Clin Rheumatol, 2012, 26:119-133.
    [28] 李栋方,唐文婷,邱坤银,等.一个常染色体显性遗传型地中海热家系的临床及遗传学分析[J].中华医学遗传学杂志, 2021, 38:719-722.
    [29] Friedman DI, Jacobson DM. Diagnostic criteria for idiopathic intracranial hypertension[J]. Neurology, 2002, 59:1492.
    [30] Gökalp HZ, Başkaya MK, Aydin V. Pseudotumor cerebri with familial Mediterranean fever[J]. Clin Neurol Neurosurg, 1992, 94:261-263.
    [31] Fischer M, Schmutzhard E. Posterior reversible encephalopathy syndrome[J]. J Neurol, 2017, 264:1608-1616.
    [32] Aksoy DY, Arici M, Kiykim AA, et al. Posterior leukoencephalopathy and nephrotic syndrome:just a coincidence?[J]. Am J Med Sci, 2004, 327:156-159.
    [33] Bartynski WS. Posterior reversible encephalopathy syndrome, part 2:controversies surrounding pathophysiology of vasogenic edema[J]. AJNR Am J Neuroradiol, 2008, 29:1043-1049.
    [34] Ulaşlı AM, Kutlu G, Kocatürk Ö, et al. Posterior reversible encephalopathy during an attack of familial Mediterranean fever[J]. Rheumatol Int, 2012, 32:1779-1781.
    [35] Abbara S, Grateau G, Ducharme-Bénard S, et al. Association of Vasculitis and Familial Mediterranean Fever[J]. Front Immunol, 2019, 10:763.
    [36] Nussinovitch U, Volovitz B, Nussinovitch M, et al. Abnormal heart rate variability in AA amyloidosis of familial Mediterranean fever[J]. Amyloid, 2011, 18:206-210.
    [37] Lavi E, Maree A, Eisenstein EM, et al. Increased prevalence of attention-deficit hyperactivity disorder symptomatology in patients with familial Mediterranean fever[J].Mod Rheumatol, 2022, 32:422-426.
    [38] Biro O, Gileles-Hillel A, Dor-Wollman T, et al. Neurological and neurodevelopmental symptoms in children with familial Mediterranean fever and their siblings[J].Eur J Pediatr, 2022, 181:973-978.
    [39] Wilbur K, Makowsky M. Colchicine myotoxicity:case reports and literature review[J]. Pharmacotherapy, 2004, 24:1784-1792.
    [40] Ben-Chetrit E, Backenroth R.Amyloidosis induced, end stage renal disease in patients with familial Mediterranean fever is highly associated with point mutations in the MEFV gene[J]. Ann Rheum Dis, 2001, 60:146-149.
  • 加载中
计量
  • 文章访问数:  76
  • HTML全文浏览量:  10
  • PDF下载量:  6
  • 被引次数: 0
出版历程
  • 收稿日期:  2022-03-01
  • 修回日期:  2022-03-21
  • 网络出版日期:  2022-10-12

目录

    /

    返回文章
    返回

    【温馨提醒】近日,《协和医学杂志》编辑部接到作者反映,有多名不法人员冒充期刊编辑发送见刊通知,鼓动作者添加微信,从而骗取版面费的行为。特提醒您,本刊与作者联系的方式均为邮件通知或电话,稿件进度通知邮箱为:mjpumch@126.com,编辑部电话为:010-69154261,请提高警惕,谨防上当受骗!如有任何疑问,请致电编辑部核实。谢谢!